Disruption of TAB1/p38α interaction using a cell-permeable peptide limits myocardial ischemia/reperfusion injury

Molecular Therapy

Volumn 21, Issue 9, 2013, Pages 1668-1677

  Wang, Qingyang ^a   Feng, Jiannan ^a   Wang, Jing ^a   Zhang, Xueying ^a   Zhang, Dalin ^a   Zhu, Ting ^a   Wang, Wendie ^a   Wang, Xiaoqian ^a   Jin, Jianfeng ^a   Cao, Junxia ^a   Li, Xinying ^a   Peng, Hui ^a   Li, Yan ^a   Shen, Beifen ^a   Zhang, Jiyan ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PENETRATING PEPTIDE; MEMBRANE PROTEIN; PEPTIDE PT5; PROTEIN P38 ALPHA; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1 BINDING PROTEIN 1; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPLEX FORMATION; COMPUTER SIMULATION; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG DESIGN; DRUG MECHANISM; DRUG SELECTIVITY; HEART MUSCLE ISCHEMIA; MOLECULAR DOCKING; MOLECULAR MODEL; NONHUMAN; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RAT; REPERFUSION INJURY; THREE DIMENSIONAL IMAGING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; DISEASE MODELS, ANIMAL; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 14; MODELS, MOLECULAR; MOLECULAR DOCKING SIMULATION; MOLECULAR SEQUENCE DATA; MYOCARDIAL REPERFUSION INJURY; PEPTIDES; PROTEIN STRUCTURE, SECONDARY; RATS;

EID: 84883740369     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2013.90     Document Type: Article

References (26)

1. Hausenloy, DJ and Yellon, DM (2013). Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest 123: 92-100.
2. Eltzschig, HK and Eckle, T (2011). Ischemia and reperfusion-from mechanism to translation. Nat Med 17: 1391-1401.
3. Denise Martin, E, De Nicola, GF and Marber, MS (2012). New therapeutic targets in cardiology: p38 alpha mitogen-activated protein kinase for ischemic heart disease. Circulation 126: 357-368.
4. Marber, MS, Rose, B and Wang, Y (2011). The p38 mitogen-activated protein kinase pathway-a potential target for intervention in infarction, hypertrophy, and heart failure. J Mol Cell Cardiol 51: 485-490.
5. Kumphune, S, Bassi, R, Jacquet, S, Sicard, P, Clark, JE, Verma, S et al. (2010). A chemical genetic approach reveals that p38alpha MAPK activation by diphosphorylation aggravates myocardial infarction and is prevented by the direct binding of SB203580. J Biol Chem 285: 2968-2975.
6. Tanno, M, Bassi, R, Gorog, DA, Saurin, AT, Jiang, J, Heads, RJ et al. (2003). Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia. Circ Res 93: 254-261. (Pubitemid 36993237)
7. Li, J, Miller, EJ, Ninomiya-Tsuji, J, Russell, RR 3rd and Young, LH (2005). AMPactivated protein kinase activates p38 mitogen-activated protein kinase by increasing recruitment of p38 MAPK to TAB1 in the ischemic heart. Circ Res 97: 872-879. (Pubitemid 41552672)
8. Fiedler, B, Feil, R, Hofmann, F, Willenbockel, C, Drexler, H, Smolenski, A et al. (2006). cGMP-dependent protein kinase type I inhibits TAB1-p38 mitogenactivated protein kinase apoptosis signaling in cardiac myocytes. J Biol Chem 281: 32831-32840. (Pubitemid 46036838)
9. Ota, A, Zhang, J, Ping, P, Han, J and Wang, Y (2010). Specific regulation of noncanonical p38alpha activation by Hsp90-Cdc37 chaperone complex in cardiomyocyte. Circ Res 106: 1404-1412.
10. Ge, B, Gram, H, Di Padova, F, Huang, B, New, L, Ulevitch, RJ et al. (2002). MAPKK-independent activation of p38alpha mediated by TAB1-dependent autophosphorylation of p38alpha. Science 295: 1291-1294. (Pubitemid 34157620)
11. Zhang, J, Shen, B and Lin, A (2007). Novel strategies for inhibition of the p38 MAPK pathway. Trends Pharmacol Sci 28: 286-295. (Pubitemid 46818466)
12. Zhou, H, Zheng, M, Chen, J, Xie, C, Kolatkar, AR, Zarubin, T et al. (2006). Determinants that control the specific interactions between TAB1 and p38?. Mol Cell Biol 26: 38243834.
13. Wells, JA and McClendon, CL (2007). Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature 450: 1001-1009. (Pubitemid 350273630)
14. Fanelli, F, Menziani, C, Scheer, A, Cotecchia, S and De Benedetti, PG (1998). Ab initio modeling and molecular dynamics simulation of the alpha 1b-adrenergic receptor activation. Methods 14: 302-317.
15. Galaktionov, S, Nikiforovich, GV and Marshall, GR (2001). Ab initio modeling of small, medium, and large loops in proteins. Biopolymers 60: 153-168. (Pubitemid 32743531)
16. Garnier, J, Gibrat, JF and Robson, B (1996). GOR method for predicting protein secondary structure from amino acid sequence. Meth Enzymol 266: 540-553.
17. Ramachandran, GN (1963). Protein Structure and Crystallography. Science 141: 288-291.
18. Feng, J, Li, Y and Shen, B (2004). The design of antagonist peptide of hIL-6 based on the binding epitope of hIL-6 by computer-aided molecular modeling. Peptides 25: 1123-1131. (Pubitemid 38881652)
19. Chen, G, Han, G, Feng, J, Wang, J, Wang, R, Xu, R et al. (2009). Glutamic acid decarboxylase-derived epitopes with specific domains expand CD4(+)CD25(+) regulatory T cells. PLoS ONE 4: e7034.
20. Lu, M, Lin, SC, Huang, Y, Kang, YJ, Rich, R, Lo, YC et al. (2007). XIAP induces NF-kappaB activation via the BIR1/TAB1 interaction and BIR1 dimerization. Mol Cell 26: 689-702. (Pubitemid 46856243)
21. Borsello, T, Clarke, PG, Hirt, L, Vercelli, A, Repici, M, Schorderet, DF et al. (2003). A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia. Nat Med 9: 1180-1186. (Pubitemid 37173703)
22. Diskin, R, Lebendiker, M, Engelberg, D and Livnah, O (2007). Structures of p38alpha active mutants reveal conformational changes in L16 loop that induce autophosphorylation and activation. J Mol Biol 365: 66-76. (Pubitemid 44821197)
23. Sy, JC, Seshadri, G, Yang, SC, Brown, M, Oh, T, Dikalov, S et al. (2008). Sustained release of a p38 inhibitor from non-inflammatory microspheres inhibits cardiac dysfunction. Nat Mater 7: 863-868.
24. Lu, G, Kang, YJ, Han, J, Herschman, HR, Stefani, E and Wang, Y (2006). TAB-1 modulates intracellular localization of p38 MAP kinase and downstream signaling. J Biol Chem 281: 6087-6095. (Pubitemid 43847710)
25. Atherton, JC, Dark, JM, Garland, HO, Morgan, MR, Pidgeon, J and Soni, S (1982). Changes in water and electrolyte balance, plasma volume and composition during pregnancy in the rat. J Physiol (Lond) 330: 81-93. (Pubitemid 12024559)
26. Shi, J, Guan, J, Jiang, B, Brenner, DA, Del Monte, F, Ward, JE et al. (2010). Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a noncanonical p38alpha MAPK pathway. Proc Natl Acad Sci USA 107: 4188-4193.